Current availability: qualification conversations for a bounded research-stage evaluation. Any evaluation requires written scope, site approval, local evidence review, and applicable legal, privacy, security, governance, and regulatory review.·© 2025-2026 VitaSignal LLC. All rights reserved.

    Video overview

    VitaSignal Clinical AI Governance Overview

    See how VitaSignal organizes intended use, evidence, local data conditions, material risks, required controls, unresolved questions, and stopping conditions for accountable human review.

    Captions are burned into the video. Sound is available; playback does not start automatically.

    What the overview covers

    • Intended use

      The single decision under review, stated plainly.

    • Evidence and limits

      What the retrospective record supports, and what it does not.

    • Local data conditions

      Documentation pathway fields, gaps, and missingness.

    • Risks and controls

      Material risks with the controls required to hold them.

    • Open questions

      What remains unresolved before anything advances.

    • Stopping conditions

      The conditions under which the evaluation stops.

    This demonstration uses generated data. It does not show a live EHR connection, customer deployment, clinical workflow integration, or patient-care use. The examples do not establish clinical utility, improved outcomes, savings, or deployment readiness. VitaSignal organizes the evidence. The health system decides.

    Want to walk through the scenario at your own pace?Open the interactive product tour